Product image of Neomycinum Tzf (Neomycin Sulfate) supplied by GNH India

Neomycinum Tzf

Active Ingredient:
Neomycin Sulfate
Origin:
EU

Neomycinum Tzf (Neomycin Sulfate)

Neomycin Sulfate, the active ingredient in Neomycinum Tzf, is an aminoglycoside antibiotic presented as a topical preparation for skin use. It treats superficial bacterial skin infections in both adults and children.
GNH India supplies Neomycinum Tzf as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Tarchomińskie Zakłady Farmaceutyczne "polfa" Spółka Akcyjna

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Neomycinum Tzf is a topical aminoglycoside used to manage bacterial skin conditions.

  • Impetigo: reduces bacterial load and promotes healing of infected lesions.
  • Minor cuts and abrasions: prevents bacterial colonisation and supports wound closure.
  • Superficial burns: limits infection risk and aids tissue recovery.
  • Infected eczema: controls secondary bacterial infection and alleviates inflammation.
  • Folliculitis: eradicates causative bacteria and reduces pustule formation.

How It Works

  • Neomycin Sulfate exerts its antibacterial effect by binding to the 30S subunit of bacterial ribosomes. This interaction interferes with the initiation complex of protein synthesis, causing misreading of mRNA and ultimately leading to bacteriostatic or bactericidal activity against susceptible Gram‑negative and some Gram‑positive organisms.

Side Effects

Topical application of Neomycinum Tzf may cause local reactions.

Common Side Effects

  • Skin irritation: mild redness or discomfort at the application site.
  • Itching: localized pruritus following use.
  • Burning sensation: transient warmth or stinging.
  • Dryness: reduced skin moisture.
  • Contact dermatitis: eczematous rash in sensitive individuals.
  • Hyperpigmentation: temporary darkening of treated skin.

Serious or Rare Side Effects

  • Allergic reaction: urticaria, angioedema, or anaphylaxis.
  • Stevens‑Johnson syndrome: severe mucocutaneous blistering.
  • Toxic epidermal necrolysis: extensive skin detachment.
  • Systemic toxicity: rare nephrotoxicity or ototoxicity if absorbed in large amounts.
  • Severe contact dermatitis: intense inflammation requiring medical attention.
  • Delayed wound healing: prolonged infection due to resistance.

Precautions & Warnings

When using Neomycinum Tzf, consider the following safety measures.

  • Allergy assessment: avoid use in patients with known hypersensitivity to neomycin or other aminoglycosides.
  • Pregnancy and lactation: consult a healthcare professional before application.
  • Extent of application: limit to small areas to minimise systemic absorption.
  • Duration of therapy: discontinue once infection resolves or after the prescribed period.
  • Storage: Store at below 25°C: keep in the original container, protect from moisture and light.

Avoid Interactions

Neomycinum Tzf may interact with other medicines or topical agents.

Major Interactions (Avoid)

  • Systemic aminoglycosides: concurrent use may increase risk of nephro‑ or ototoxicity.
  • Other topical antibiotics: combined use can heighten local irritation.
  • Silver‑containing dressings: may reduce antibacterial efficacy.

Moderate Interactions (Monitor Closely)

  • Topical corticosteroids: may mask signs of infection, requiring close observation.
  • Antiseptic solutions (e.g., chlorhexidine): could alter drug absorption.
  • Occlusive dressings: may increase local drug concentration and irritation.

Frequently Asked Questions

Neomycinum Tzf is a topical formulation containing Neomycin Sulfate. It is used to treat superficial bacterial skin infections such as impetigo, minor cuts, abrasions, superficial burns, infected eczema and folliculitis by eliminating susceptible bacteria at the site of application.

Neomycin Sulfate belongs to the aminoglycoside class. It binds to the 30S ribosomal subunit of bacteria, disrupting the initiation of protein synthesis. This leads to misreading of messenger RNA and ultimately inhibits bacterial growth or kills the organism.

The dosage and frequency of Neomycinum Tzf are determined by the prescribing healthcare professional based on the type and severity of the skin infection, the patient’s age, and the area of application. Patients should follow the prescriber’s instructions exactly.

Safety data for topical Neomycin Sulfate in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

To order Neomycinum Tzf, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Neomycinum Tzf offers broad‑spectrum activity against many Gram‑negative and some Gram‑positive bacteria, similar to other aminoglycoside‑based creams. Compared with bacitracin or mupirocin, neomycin may have a higher risk of contact dermatitis but is often combined with other agents for synergistic effect.

Neomycinum Tzf should be stored at temperatures below 25 °C, in its original packaging, protected from moisture and direct light. Keep the container tightly closed when not in use to maintain product stability.

The product is applied topically to the affected skin area. A thin layer should be spread over the lesion and gently massaged in, usually 2‑3 times daily or as directed by a healthcare professional. Hands should be washed before and after application.

Serious risks include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome, toxic epidermal necrolysis, and, rarely, systemic toxicity (nephrotoxicity or ototoxicity) if significant absorption occurs. Immediate medical attention is required if any of these symptoms develop.

Individuals with a known hypersensitivity to neomycin, other aminoglycosides, or any component of the formulation should avoid using Neomycinum Tzf. It is also contraindicated in patients with pre‑existing severe kidney or ear disorders when systemic exposure is possible.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Neomycin Sulfate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT